Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Andreas, Melidonis"'
Publikováno v:
Archives of Medical Science, Vol 20, Iss 1, Pp 207-215 (2024)
Introduction Material and methods Results Conclusions
Externí odkaz:
https://doaj.org/article/6fd0565a4f4246b79a2ed653f684172b
Autor:
Genovefa Kolovou, Vana Kolovou, Helen Bilianou, Georgios Goumas, Stefanos Foussas, Eirini Grapsa, Anastasia Garoufi, Georgios Karavolias, Sophie Mavrogieni, Andreas Melidonis, Haralampos Milionis, Loukianos Rallidis, Dimitris Richter, Ioannis Skoumas, Dimitris Tousoulis, Charalambos Vlachopoulos, Evangelos Liberopoulos
Publikováno v:
Hellenic Journal of Cardiology, Vol 62, Iss 6, Pp 460-462 (2021)
Externí odkaz:
https://doaj.org/article/d4abc27b79cf454ea401a59e657be087
Autor:
Kyriakos Souliotis, Anastasios Koutsovasilis, Georgia Vatheia, Christina Golna, Sofia Nikolaidi, Erifili Hatziagelaki, Kalliopi Kotsa, Theocharis Koufakis, Andreas Melidonis, Athanasia Papazafiropoulou, Nikolaos Tentolouris, Evangelia Siami, Alexios Sotiropoulos
Publikováno v:
BMC Endocrine Disorders, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Strict glycaemic control early in the treatment process has been shown to reduce the occurrence of micro- and macro- vascular complications of diabetes in the long-term. Thus, treatment guidelines advise early intensification of t
Externí odkaz:
https://doaj.org/article/df5bc6ab13c646b0a9fdd05170c64a25
Autor:
Andrew Xanthopoulos, Gregory Giamouzis, Andreas Melidonis, Takeshi Kitai, Efi Paraskevopoulou, Pinelopi Paraskevopoulou, Sotirios Patsilinakos, Filippos Triposkiadis, John Skoularigis
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background Red blood cell distribution width (RDW) is an established prognostic marker in acute and chronic heart failure (HF). Recent studies have pointed out a link among RDW, diabetes mellitus (DM) and inflammation. We sought to investiga
Externí odkaz:
https://doaj.org/article/0529d00aab8f406b9b8be59be055ebe1
Autor:
Andreas Melidonis
Publikováno v:
Epistīmonika Chronika, Vol 22, Iss Suppl. 1, Pp 117-124 (2017)
Metabolic syndrome is a premorbid situation, a constellation of metabolic risk factors and defines the need for clinical treatment of obese who have multiple additional risk factors. Nowadays there is a tendency of evolution of metabolic syndrome in
Externí odkaz:
https://doaj.org/article/36c5d83bed6b468c883d6451fef10546
Autor:
Georgios Kranidiotis, Efrosini Efstratiadis, Georgios Kapsalakis, Georgios Loizos, Apostolos Bilis, Andreas Melidonis
Publikováno v:
IDCases, Vol 4, Iss C, Pp 62-64 (2016)
Introduction: Human parvovirus B19 is a DNA virus most known for causing erythema infectiosum in children, and polyarthropathy or transient aplastic crisis in adults. However, various unusual clinical manifestations have also been reported in associa
Externí odkaz:
https://doaj.org/article/15cce48007f14dd18fd657e0ce42a2c4
Autor:
Evangelos Liberopoulos, Eirini Grapsa, Helen Bilianou, Loukianos S. Rallidis, Charalambos Vlachopoulos, Genovefa Kolovou, Vana Kolovou, Ioannis Skoumas, Georgios Goumas, Dimitris J. Richter, Sophie Mavrogieni, Anastasia Garoufi, Stefanos G. Foussas, Haralampos J. Milionis, Georgios Karavolias, Andreas Melidonis, Dimitris Tousoulis
Publikováno v:
Hellenic Journal of Cardiology, Vol 62, Iss 6, Pp 460-462 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffca0bf2e8ddbb9c17b68552e4306db
https://doi.org/10.1016/j.hjc.2020.12.010
https://doi.org/10.1016/j.hjc.2020.12.010
Autor:
Andreas Melidonis, Kalliopi Kotsa, Emmanouel Pagkalos, Gerasimos Karousos, Iakovos Avramidis, Katerina Pietri, Eleni Arvaniti, Ilias Migdalis, Ioannis Ioannidis, Nikolaos Papanas, Eugenia Karamousouli, John Doupis, Alexandra Bargiota, Bernd Voss, A. Pappas, Stavros Bousboulas, Nikolaos Tentolouris, Magdalini Bristianou, M.S. Elisaf
Publikováno v:
Diabetes Therapy
Introduction Physician adherence, or lack therefore, to diabetes care and follow-up guidelines may be linked to the rates of achieving suboptimal glycaemic, blood pressure and lipid targets in people with type 2 diabetes mellitus (T2DM). In this cros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b6b85a27732247bbef3ee2e45e632b
https://doi.org/10.1007/s13300-020-00935-6
https://doi.org/10.1007/s13300-020-00935-6
Autor:
Genovefa Kolovou, Niki Katsiki, Andreas Melidonis, Athanasios J. Manolis, Nikoletta Karampetsou, Dimitri P. Mikhailidis, Stamatis S. Makrygiannis, Vana Kolovou, Sophie Mavrogieni
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 26:51-58
Aim:We evaluated the lipid-lowering (LL) effect of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in patients with heterozygous familial hypercholesterolemia (HeFH) treated with LL-drugs and lipoprotein apheresis (LA).Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc45cce04a543bdf820acc326f0ac2fc
https://doi.org/10.1177/1074248420943079
https://doi.org/10.1177/1074248420943079
Publikováno v:
Archives of Medical Sciences. Atherosclerotic Diseases
Patients with type 2 diabetes are at high risk for cognitive decline and dementia. Despite the limited data on the possible pathogenetic mechanisms, evidence suggests that cognitive decline, and thus dementia and Alzheimer’s disease, might arise fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0b00dd0c815436c8f54ae4203388dc
https://doi.org/10.5114/amsad.2020.97433
https://doi.org/10.5114/amsad.2020.97433